During this session you can expect to hear about the latest advances using iPSC-derived cells in complex models and regenerative medicine applications, such as the formation of organotypic tissue systems, the repair of human tissues and the bioengineering of transplantable human organs using various technologies.
With many potential new drugs failing to launch because of toxicity issues, there is a need for better tools to assess toxicity liability. Session speakers will present data demonstrating that the consistent biology, abundant supply, and reproducible results provided by iPSC-derived cells enable them to predict toxicity early in the discovery process.
Have a poster you want to present at iForum℠ 2017 meetings? Please send us a short description to join the discussion.
Submit an Abstract
iForum℠ meetings provide a unique opportunity to increase product awareness and showcase the utility and benefits of your products and services.
See the Prospectus